Jiangsu Hengrui Pharmaceuticals Co Ltd (HKSE:01276) Share Price

Company Profile

Business description
Jiangsu Hengrui Pharmaceuticals Co Ltd is a biopharmaceutical company that engages in the research, development, manufacture, and sale of drugs. It is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs, and anti-infection medications. The company specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system. Geographically, the company is segmented as Chinese mainland and Other countries generating majority revenue from the Chinese region.
Contact
No. 7, Kunlunshan Road
Economic and Technological Development Zone
Jiangsu Province
Lianyugang222000
CHN
T: +86 4008283900
https://www.hengrui.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
20,602

Recommended

We think the floundering stock price is not reflective of underlying asset value.

Brian Han | 10 April 2026

Near-term cost growth does not change our long-term view.

Shane Ponraj, CFA | 10 April 2026

US stores are struggling, but our investment thesis hinges on the Australian rollout.

Johannes Faul, CFA | 09 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,155.80	34.00	0.37%
CAC 40	8,259.60	13.81	0.17%
DAX 40	23,803.95	3.04	-0.01%
Dow JONES (US)	47,916.57	269.23	-0.56%
FTSE 100	10,600.53	2.95	-0.03%
HKSE	25,893.54	141.14	0.55%
NASDAQ	22,902.89	80.48	0.35%
Nikkei 225	56,924.11	1,028.79	1.84%
NZX 50 Index	13,181.44	92.37	-0.70%
S&P 500	6,816.89	7.77	-0.11%
S&P/ASX 200	8,960.60	36.20	0.41%
SSE Composite Index	3,986.22	20.05	0.51%